Pediatric Clinical Trials

Pediatric Lymphoma

If you would like to inquire about all open trials, please contact 919.684.3401.

4 trials identified.

ANHL04B1 Rare and Cutaneous Non-Hodgkin Lymphoma Registry
Phase: N/A
Sponsor: Cooperative Group Initiated
Principal Investigator: Susan Kreissman
Contact: Dr. Susan Kreissman
Phone: 919.684.3401
Reference Number: 00000017
View this trial at ClinicalTrials.gov

ANHL12P1 A Randomized Phase 2 study of Brentuximab Vedotin (NSC# 749710) and Crizotinib (NSC# 749005) in Patients with Newly Diagnosed Anaplastic Large Cell Lymphoma (ALCL) IND #117117
Phase: Phase II
Sponsor: Cooperative Group Initiated
Principal Investigator: Susan Kreissman
Contact: Dr. Susan Kreissman
Phone: 919.684.3401
Reference Number: 00051843
View this trial at ClinicalTrials.gov

A Multicenter Pilot Study of Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Targeted Immunotherapy in Children, Adolescents and Young Adults with Poor Risk CD30+ Hodgkin Lymphoma (HL) A Childhood, Adolescent and Young Adult Lymphoma Cell Therapy Consortium (LCTC) and Limited Pediatric Blood and Marrow Transplant Consortium (PBMTC) Multicenter Clinical Trial
Phase: Phase I
Sponsor: External Investigator-Sponsored (External Med Ctr)
Principal Investigator: Paul Martin
Contact: Jennifer Baker, RN
Phone: 919.668.1100
Reference Number: 00062316
View this trial at ClinicalTrials.gov

AHOD1331 A Randomized Phase III Study of Brentuximab Vedotin (SGN-35, IND #117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents
Phase: Phase III
Sponsor: Cooperative Group Initiated
Principal Investigator: Susan Kreissman
Contact: Dr. Susan Kreissman
Phone: 919.684.3041
Reference Number: 00065203
View this trial at ClinicalTrials.gov